157 related articles for article (PubMed ID: 18409188)
1. A DNA resequencing array for pathogenic mutation detection in hypertrophic cardiomyopathy.
Fokstuen S; Lyle R; Munoz A; Gehrig C; Lerch R; Perrot A; Osterziel KJ; Geier C; Beghetti M; Mach F; Sztajzel J; Sigwart U; Antonarakis SE; Blouin JL
Hum Mutat; 2008 Jun; 29(6):879-85. PubMed ID: 18409188
[TBL] [Abstract][Full Text] [Related]
2. Additional value of screening for minor genes and copy number variants in hypertrophic cardiomyopathy.
Mademont-Soler I; Mates J; Yotti R; Espinosa MA; Pérez-Serra A; Fernandez-Avila AI; Coll M; Méndez I; Iglesias A; Del Olmo B; Riuró H; Cuenca S; Allegue C; Campuzano O; Picó F; Ferrer-Costa C; Álvarez P; Castillo S; Garcia-Pavia P; Gonzalez-Lopez E; Padron-Barthe L; Díaz de Bustamante A; Darnaude MT; González-Hevia JI; Brugada J; Fernandez-Aviles F; Brugada R
PLoS One; 2017; 12(8):e0181465. PubMed ID: 28771489
[TBL] [Abstract][Full Text] [Related]
3. Evaluating the Clinical Validity of Hypertrophic Cardiomyopathy Genes.
Ingles J; Goldstein J; Thaxton C; Caleshu C; Corty EW; Crowley SB; Dougherty K; Harrison SM; McGlaughon J; Milko LV; Morales A; Seifert BA; Strande N; Thomson K; Peter van Tintelen J; Wallace K; Walsh R; Wells Q; Whiffin N; Witkowski L; Semsarian C; Ware JS; Hershberger RE; Funke B
Circ Genom Precis Med; 2019 Feb; 12(2):e002460. PubMed ID: 30681346
[TBL] [Abstract][Full Text] [Related]
4. The Definition of Sarcomeric and Non-Sarcomeric Gene Mutations in Hypertrophic Cardiomyopathy Patients: A Multicenter Diagnostic Study Across Türkiye.
Oktay V; Tüfekçioğlu O; Yılmaz DÇ; Onrat E; Karabulut D; Çelik M; Balcıoğlu AS; Sucu MM; Özdemir G; Kaya H; Kış M; Güven B; Bağdatoğlu O; Turhan Çağlar FN; Yüksel UÇ; Düzen İV; Barutçu A; Şimşir ÖS; Başarıcı İ; Parspur A; Dalgıç O; Arıcan Özlük FÖ; Evlice M; Sağ S; Deniz MF; Öcal A; Gazi E; Şen T; Özdabakoğlu O; Bayar Çakıcı N; Bakır EO; Ülgen Kunak A; Çaylı G; Gül Taşdelen A; Akşit E; Uslu Çil Ş; Onay H
Anatol J Cardiol; 2023 Nov; 27(11):628-638. PubMed ID: 37466024
[TBL] [Abstract][Full Text] [Related]
5. Sarcomeric gene variants among Indians with hypertrophic cardiomyopathy: A scoping review.
Koshy L; Ganapathi S; Jeemon P; Madhuma M; Vysakh Y; Lakshmikanth LR; Harikrishnan S
Indian J Med Res; 2023 Aug; 158(2):119-135. PubMed ID: 37787257
[TBL] [Abstract][Full Text] [Related]
6. Signal-to-Noise Analysis Can Inform the Likelihood That Incidentally Identified Variants in Sarcomeric Genes Are Associated with Pediatric Cardiomyopathy.
Kurzlechner LM; Jones EG; Berkman AM; Tadros HJ; Rosenfeld JA; Yang Y; Tunuguntla H; Allen HD; Kim JJ; Landstrom AP
J Pers Med; 2022 Apr; 12(5):. PubMed ID: 35629155
[TBL] [Abstract][Full Text] [Related]
7. Identification of variants in genes associated with hypertrophic cardiomyopathy in Mexican patients.
García-Vielma C; Lazalde-Córdova LG; Arzola-Hernández JC; González-Aceves EN; López-Zertuche H; Guzmán-Delgado NE; González-Salazar F
Mol Genet Genomics; 2023 Nov; 298(6):1289-1299. PubMed ID: 37498360
[TBL] [Abstract][Full Text] [Related]
8. Role of Genetics in Diagnosis and Management of Hypertrophic Cardiomyopathy: A Glimpse into the Future.
Abbas MT; Baba Ali N; Farina JM; Mahmoud AK; Pereyra M; Scalia IG; Kamel MA; Barry T; Lester SJ; Cannan CR; Mital R; Wilansky S; Freeman WK; Chao CJ; Alsidawi S; Ayoub C; Arsanjani R
Biomedicines; 2024 Mar; 12(3):. PubMed ID: 38540296
[TBL] [Abstract][Full Text] [Related]
9. Evolution of genetic testing and gene therapy in hypertrophic cardiomyopathy.
Chiswell K; Zaininger L; Semsarian C
Prog Cardiovasc Dis; 2023; 80():38-45. PubMed ID: 37137376
[TBL] [Abstract][Full Text] [Related]
10. Ethnicity, consanguinity, and genetic architecture of hypertrophic cardiomyopathy.
Allouba M; Walsh R; Afify A; Hosny M; Halawa S; Galal A; Fathy M; Theotokis PI; Boraey A; Ellithy A; Buchan R; Govind R; Whiffin N; Anwer S; ElGuindy A; Ware JS; Barton PJR; Yacoub M; Aguib Y
Eur Heart J; 2023 Dec; 44(48):5146-5158. PubMed ID: 37431535
[TBL] [Abstract][Full Text] [Related]
11. Phospholamban p.Leu39* Cardiomyopathy Compared with Other Sarcomeric Cardiomyopathies: Age-Matched Patient Cohorts and Literature Review.
Afana AS; Vasiliu L; Sascău R; Adam RD; Rădulescu C; Onciul S; Cinteză E; Chirita-Emandi A; Jurcuț R
J Cardiovasc Dev Dis; 2024 Jan; 11(2):. PubMed ID: 38392255
[TBL] [Abstract][Full Text] [Related]
12. Allele-Specific Suppression of Variant MHC With High-Precision RNA Nuclease CRISPR-Cas13d Prevents Hypertrophic Cardiomyopathy.
Yang P; Lou Y; Geng Z; Guo Z; Wu S; Li Y; Song K; Shi T; Zhang S; Xiong J; Chen AF; Li D; Pu WT; Da L; Zhang Y; Sun K; Zhang B
Circulation; 2024 May; ():. PubMed ID: 38752340
[TBL] [Abstract][Full Text] [Related]
13. Pediatric hypertrophic cardiomyopathy caused by a novel TNNI3 variant.
Inagaki N; Okano T; Kobayashi M; Fujii M; Yazaki Y; Takei Y; Kosuge H; Suzuki S; Hayashi T; Kuroda M; Satomi K
Hum Genome Var; 2024 Mar; 11(1):14. PubMed ID: 38548731
[TBL] [Abstract][Full Text] [Related]
14. Reassessment of Mendelian gene pathogenicity using 7,855 cardiomyopathy cases and 60,706 reference samples.
Walsh R; Thomson KL; Ware JS; Funke BH; Woodley J; McGuire KJ; Mazzarotto F; Blair E; Seller A; Taylor JC; Minikel EV; Exome Aggregation Consortium ; MacArthur DG; Farrall M; Cook SA; Watkins H
Genet Med; 2017 Feb; 19(2):192-203. PubMed ID: 27532257
[TBL] [Abstract][Full Text] [Related]
15. Actionable exomic incidental findings in 6503 participants: challenges of variant classification.
Amendola LM; Dorschner MO; Robertson PD; Salama JS; Hart R; Shirts BH; Murray ML; Tokita MJ; Gallego CJ; Kim DS; Bennett JT; Crosslin DR; Ranchalis J; Jones KL; Rosenthal EA; Jarvik ER; Itsara A; Turner EH; Herman DS; Schleit J; Burt A; Jamal SM; Abrudan JL; Johnson AD; Conlin LK; Dulik MC; Santani A; Metterville DR; Kelly M; Foreman AK; Lee K; Taylor KD; Guo X; Crooks K; Kiedrowski LA; Raffel LJ; Gordon O; Machini K; Desnick RJ; Biesecker LG; Lubitz SA; Mulchandani S; Cooper GM; Joffe S; Richards CS; Yang Y; Rotter JI; Rich SS; O'Donnell CJ; Berg JS; Spinner NB; Evans JP; Fullerton SM; Leppig KA; Bennett RL; Bird T; Sybert VP; Grady WM; Tabor HK; Kim JH; Bamshad MJ; Wilfond B; Motulsky AG; Scott CR; Pritchard CC; Walsh TD; Burke W; Raskind WH; Byers P; Hisama FM; Rehm H; Nickerson DA; Jarvik GP
Genome Res; 2015 Mar; 25(3):305-15. PubMed ID: 25637381
[TBL] [Abstract][Full Text] [Related]
16. Mutations in the gene for cardiac myosin-binding protein C and late-onset familial hypertrophic cardiomyopathy.
Niimura H; Bachinski LL; Sangwatanaroj S; Watkins H; Chudley AE; McKenna W; Kristinsson A; Roberts R; Sole M; Maron BJ; Seidman JG; Seidman CE
N Engl J Med; 1998 Apr; 338(18):1248-57. PubMed ID: 9562578
[TBL] [Abstract][Full Text] [Related]
17. A systematic approach to assessing the clinical significance of genetic variants.
Duzkale H; Shen J; McLaughlin H; Alfares A; Kelly MA; Pugh TJ; Funke BH; Rehm HL; Lebo MS
Clin Genet; 2013 Nov; 84(5):453-63. PubMed ID: 24033266
[TBL] [Abstract][Full Text] [Related]
18. Prevalence and spectrum of mutations in a cohort of 192 unrelated patients with hypertrophic cardiomyopathy.
Millat G; Bouvagnet P; Chevalier P; Dauphin C; Jouk PS; Da Costa A; Prieur F; Bresson JL; Faivre L; Eicher JC; Chassaing N; Crehalet H; Porcher R; Rodriguez-Lafrasse C; Rousson R
Eur J Med Genet; 2010; 53(5):261-7. PubMed ID: 20624503
[TBL] [Abstract][Full Text] [Related]
19. An international compendium of mutations in the SCN5A-encoded cardiac sodium channel in patients referred for Brugada syndrome genetic testing.
Kapplinger JD; Tester DJ; Alders M; Benito B; Berthet M; Brugada J; Brugada P; Fressart V; Guerchicoff A; Harris-Kerr C; Kamakura S; Kyndt F; Koopmann TT; Miyamoto Y; Pfeiffer R; Pollevick GD; Probst V; Zumhagen S; Vatta M; Towbin JA; Shimizu W; Schulze-Bahr E; Antzelevitch C; Salisbury BA; Guicheney P; Wilde AA; Brugada R; Schott JJ; Ackerman MJ
Heart Rhythm; 2010 Jan; 7(1):33-46. PubMed ID: 20129283
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
